San Diego-based Sorrento Therapeutics, a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. The firm is headed by Antonius Schuh, who serves as founding chairman and CEO; the firm's CFO is Steve Zaniboni. Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. More information »